the role of interferon in polycythemia vera & perspectives on the management of low-risk patients
Published 1 year ago • 1.1K plays • Length 6:49Download video MP4
Download video MP3
Similar videos
-
1:01
the role of interferon in pv
-
4:30
update on the use of interferon-alfa for polycythemia vera
-
6:19
management of patients with pv who are intolerant to interferon and who develop post-polycythemic mf
-
2:02
conti-pv: a 2-year follow-up of interferon product aop2014
-
2:06
clinical updates on the use of ropeginterferon for polycythemia vera
-
6:15
interferon’s role in treating polycythemia vera
-
2:25
interferons in the treatment of mpns: clinical trials in 2021
-
15:35
ori bio
-
30:17
ask the expert: polycythemia vera
-
32:29
current developments in polycythemia vera treatment: is it curable?
-
1:01
exploring the biological mechanisms driving mbl progression to cll
-
2:16
ropeginterferon vs standard therapy for polycythemia vera
-
4:28
management of pv, the role of interferon
-
1:59
mpd-rc 112 trial of pegylated interferon alpha-2a for polycythemia vera & essential thrombocythemia
-
3:09
pegylated interferon for the treatment of polycythemia vera and essential thrombocythemia
-
1:29
ropeginterferon alfa-2b for polycythemia vera: impacts and considerations
-
2:14
risk-adapted treatment of et & pv
-
6:31
the current treatment landscape for polycythemia vera
-
2:55
interferons and myeloproliferative neoplasms (mpns)
-
2:05
the changing approaches to polycythemia vera: a clinical perspective
-
3:10
promising trials in polycythemia vera
-
2:54
an update on the use of idasanutlin in polycythemia vera